ロード中...
Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients
BACKGROUND: Exenatide once weekly (QW) is a glucagon-like peptide-1 receptor agonist (GLP-1RA) for the treatment of type 2 diabetes. Safety and tolerability are key considerations in treatment selection. This analysis examines the safety and tolerability profile of exenatide QW, other approved GLP-1...
保存先:
| 出版年: | Diabetes Metab Syndr Obes |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4445788/ https://ncbi.nlm.nih.gov/pubmed/26056482 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S77290 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|